VIM and hepatocellular carcinoma: Inactivation of miR-483 using an inhibitor increased Vimentin in all three cell lines studied, suggesting that miR-483 suppresses EMT in HepaRG and HCC cells and inactivation of endogenous miR-483 promotes EMT in a cell dependent manner (Figure 3D).